Updated on 22 September 2026
Clinical Research Partner in Armenia for Neurology and Neurodegenerative Diseases
Deputy Director for Scientific Development at NeuroKlinik – German Center for Neurology in Armenia
Yerevan, Armenia
About
NeuroKlinik is a specialized neurological clinical center based in Yerevan, Armenia, providing neurological diagnostics, treatment and multidisciplinary rehabilitation. Our clinical team includes specialists with extensive training and professional experience in Germany, combining European clinical standards with direct access to neurological patient populations in Armenia.
We are interested in participating as a clinical partner in European and international multicentre research, particularly in neurological and neurodegenerative diseases.
Our main interests include clinical trials of innovative interventions, disease progression, clinical outcomes, prevention, predictive and clinical biomarkers, digital health, and the translation of research findings into clinical practice.
NeuroKlinik can contribute a clinical research setting in Armenia, neurological expertise, access to relevant patient populations, patient recruitment, clinical assessment, neurophysiological evaluation, data collection and follow-up.
We are particularly interested in joining established or developing consortia seeking clinical partners and in contributing Armenia as a clinical research site to European multicentre studies.
Topic
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases
- Digital health and AI: HORIZON-HLTH-2027-02-TOOL-01-two-stage Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
Empowering neurodegenerative disease trials
- Partner seeks Consortium/Coordinator
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases
Chiheb Guerfel
Chief Executive Officer at Poseidon CRO ( Poseidon Research Balkans d.o.o. )
Novi Sad, Serbia
Project cooperation
Clinical Studies for Horizon Europe Cluster Health 2027
- Partner seeks Consortium/Coordinator
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases
- Clinical trials: HORIZON-HLTH-2027-01-DISEASE-10 Prevention and management of chronic non-communicable diseases in children and young people (GACD)
- Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Juan Abolafia
Head EU office at Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer
Barcelona, Spain
Project cooperation
Medical-grade remote monitoring and digital endpoints for NCD and neurodegenerative clinical trials
- Partner seeks Consortium/Coordinator
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases
Kai Gand
Grants Manager at Corsano Health
The Hague, Netherlands